Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)

BACKGROUND: Although de novo stage IV breast cancer is so far incurable, it has entered an era of individualized treatment and chronic disease management. Based on systemic treatment, whether the surgical resection of primary or metastatic foci of de novo stage IV breast cancer can bring survival be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ang, Guo, Bao-Liang, Zhang, Jian-Guo, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280017/
https://www.ncbi.nlm.nih.gov/pubmed/34101635
http://dx.doi.org/10.1097/CM9.0000000000001415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280017/
https://www.ncbi.nlm.nih.gov/pubmed/34101635
http://dx.doi.org/10.1097/CM9.0000000000001415

Ejemplares similares